Tech Company Financing Transactions
Cardeas Pharma Funding Round
Cardeas Pharma closed a $5 million funding round on 12/20/2011. Investors included De Novo Ventures, Avalon Ventures and Devon Park Bioventures.
Transaction Overview
Company Name
Announced On
12/20/2011
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company plans to use the money to run both preclinical experiments and initial clinical trials of a novel therapeutic to be used in hospitals.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2025 1st Ave. 1200
Seattle, WA 98121
USA
Seattle, WA 98121
USA
Phone
Website
Email Address
Not Recorded
Overview
Cardeas Pharma specializes in early-phase development of inhaled antibiotics to treat respiratory infections.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bruce Montgomery
Chief Operating Officer
Melissa Yeager
Browse more venture capital transactions:
Prev: 12/20/2011: ReVision Therapeutics venture capital transaction
Next: 12/20/2011: eRecyclingCorps venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs